Search
for
Sort by
Research 691–720 of 1000+
- Reconsidering the classification of vitiligo and alopecia as cosmetic concerns in Medicaid and Tricare policies
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Upadacitinib for the treatment of alopecia areata – A case report
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- Analysis of Histology and Long Noncoding RNAs Involved in the Rabbit Hair Follicle Density using RNA Sequencing
- Hair follicle immune privilege and its collapse in alopecia areata
- Cell fate decisions: emerging roles for metabolic signals and cell morphology
- Stimulation of Hair Growth by Small Molecules that Activate Autophagy
- Frontiers in alopecia areata pathobiology research
- The influence of interferon on healthy and diseased skin
- Conventional and novel stem cell based therapies for androgenic alopecia
- Xinyang tablet ameliorates sepsis-induced myocardial dysfunction by regulating Beclin-1 to mediate macrophage autophagy and M2 polarization through LncSICRNT1 targeting E3 ubiquitin ligase TRAF6
- Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson–Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies
- Multi-omics analyses, cell experiments, and network pharmacology tools identified key proteins and candidate drugs for alopecia areata treatment
- Proceedings of the Ninth World Congress for Hair Research (2015)
- Metabolic Syndrome and Skin Diseases
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- The role of leptin in selected skin diseases
- Regulatory Processes of the Canonical Wnt/β-Catenin Pathway and Photobiomodulation in Diabetic Wound Repair
- Metabolic syndrome and dermatological diseases: association and treatment
- IL-15 Prolongs Anagen, Stimulates Proliferation, and Suppresses Apoptosis in the Hair Matrix of Human Scalp Hair Follicles
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
- Tissue Retinol‐Binding Protein 4 Expression and Its Genetic Variants (rs3758539) in Patients With Severe and Treatment‐Refractory Alopecia Areata: Association With Response to Baricitinib
- Iron–Skin Axis: Exploring the Interplay between Iron Homeostasis and Skin Disorders
- Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis.